Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan-Manuel Campos

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Best Practice & Research. Clinical Anaesthesiology|January 14, 2009
Hypothermia during cardiac surgeryJuan-Manuel Campos, Pilar Paniagua
Medicina Clinica|June 9, 2006
[Anesthesia practice in Catalan hospitals and other health care facilities]Antonio Villalonga, Sergi Sabaté, Juan Manuel Campos, et al.
Journal of Wildlife Diseases|January 15, 2005
Immobilization of Chacoan peccaries (Catagonus wagneri) using medetomidine, Telazol, and ketamineMeg Sutherland-Smith, Juan Manuel Campos, Carrie Cramer, et al.
The Cochrane Database of Systematic Reviews|April 22, 2016
Active body surface warming systems for preventing complications caused by inadvertent perioperative hypothermia in adultsEva Madrid, Gerard Urrútia, Marta Roqué i Figuls, et al.
Angiogenesis|May 6, 2014
The role of antiangiogenic agents in the treatment of patients with advanced colorectal cancer according to K-RAS statusPilar García-Alfonso, Enrique Grande, Eduardo Polo, et al.
Anti-Cancer Drugs|October 1, 2004
Phase II study of irinotecan (CPT-11) administered every 2 weeks as treatment for patients with colorectal cancer resistant to previous treatment with 5-fluorouracil-based therapies: comparison of two different dose schedules (250 and 200 mg/m2) according to toxicity prognostic factorsEugeni Saigi, Antonieta Salut, Juan Manuel Campos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 18, 2011
Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancerCarles Pericay Pijaume, Pilar Escudero Emperador, Román Bastús Piulats, et al.
European Journal of Cancer (Oxford, England : 1990)|October 11, 2005
Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancerMiquel Nogué, Antonieta Salud, Eduard Batiste-Alentorn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2004
Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years' follow-UpCarlos Fernández-Martos, Jorge Aparicio, Carles Bosch, et al.
Marine Pollution Bulletin|November 20, 2019
Silver and copper as pollution tracers in Neogene to Holocene estuarine sediments from southwestern SpainFrancisco Ruiz, Joaquín Rodríguez Vidal, Luis Miguel Cáceres, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Best Practice & Research. Clinical Anaesthesiology|January 14, 2009
Hypothermia during cardiac surgeryJuan-Manuel Campos, Pilar Paniagua
Medicina Clinica|June 9, 2006
[Anesthesia practice in Catalan hospitals and other health care facilities]Antonio Villalonga, Sergi Sabaté, Juan Manuel Campos, et al.
Journal of Wildlife Diseases|January 15, 2005
Immobilization of Chacoan peccaries (Catagonus wagneri) using medetomidine, Telazol, and ketamineMeg Sutherland-Smith, Juan Manuel Campos, Carrie Cramer, et al.
The Cochrane Database of Systematic Reviews|April 22, 2016
Active body surface warming systems for preventing complications caused by inadvertent perioperative hypothermia in adultsEva Madrid, Gerard Urrútia, Marta Roqué i Figuls, et al.
Angiogenesis|May 6, 2014
The role of antiangiogenic agents in the treatment of patients with advanced colorectal cancer according to K-RAS statusPilar García-Alfonso, Enrique Grande, Eduardo Polo, et al.
Anti-Cancer Drugs|October 1, 2004
Phase II study of irinotecan (CPT-11) administered every 2 weeks as treatment for patients with colorectal cancer resistant to previous treatment with 5-fluorouracil-based therapies: comparison of two different dose schedules (250 and 200 mg/m2) according to toxicity prognostic factorsEugeni Saigi, Antonieta Salut, Juan Manuel Campos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 18, 2011
Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancerCarles Pericay Pijaume, Pilar Escudero Emperador, Román Bastús Piulats, et al.
European Journal of Cancer (Oxford, England : 1990)|October 11, 2005
Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancerMiquel Nogué, Antonieta Salud, Eduard Batiste-Alentorn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2004
Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years' follow-UpCarlos Fernández-Martos, Jorge Aparicio, Carles Bosch, et al.
Marine Pollution Bulletin|November 20, 2019
Silver and copper as pollution tracers in Neogene to Holocene estuarine sediments from southwestern SpainFrancisco Ruiz, Joaquín Rodríguez Vidal, Luis Miguel Cáceres, et al.
Pageof 2